Rocket Lab (RKLB)'s stock surged 45%, in the past three months, driven not only by a robust 10% increase in revenue but also by a significant 36% uplift in valuation.
Rocket Lab (RKLB) nearly hit $100 on Friday after Morgan Stanley upgraded the space tech company. George Tsilis talks about the company's satellite business as a main catalyst to the positive price action even as some analysts sit on the sidelines.
Rocket Lab Corporation is positioned for ~$900M in revenue in 2026 as Defense and Space Systems backlog converts. Space Systems should drive sustained 30%+ growth via multi-year national security programs. Electron is expected to maintain 20+ launches annually, anchoring reliability and execution credibility.
“What more do you want?” asked KeyBanc analysts led by Michael Leshock in a late Wednesday note downgrading Rocket Lab shares to sector weight from overweight.
Rocket Lab (RKLB) has delivered over 550% returns since my November 2024 'Buy' rating initiation. The upcoming Neutron rocket launch in mid-2026 is a major catalyst, targeting the lucrative medium-lift constellation market with a reusable, cost-effective design. I think RKLB is nearing an EBITDA breakeven point as R&D spending on Neutron peaks and gross margins expand toward a non-GAAP target of 44%.
The latest trading day saw Rocket Lab Corporation (RKLB) settling at $86.58, representing a -1.5% change from its previous close.
Rocket Lab secured an $816M U.S. Space Development Agency contract, marking its largest and a pivotal defense sector win. RKLB's space systems segment, not launches, is the primary growth driver, with proprietary tech like Phoenix and StarLite gaining government validation. Valuation is stretched at 79x EV/sales, reflecting high-growth expectations but leaving little room for execution missteps.
Subscribers to Schaeffer's Weekend Trader options recommendation service received this RKLB commentary on Sunday night, along with a detailed options trade recommendation -- including complete entry and exit parameters.
Momentum is running hot for Rocket Lab NASDAQ: RKLB, as shares continue to surge to fresh all-time highs. The aerospace and defense company has been a consistent focus of MarketBeat in recent months, with specific attention paid to its expanding contract pipeline, increasingly constructive technical setup, and sector-wide momentum.
Rocket Lab Corporation is rated a Strong Buy as it approaches profitability and demonstrates accelerating revenue growth. RKLB delivered a major EPS beat in Q3 (-$0.02 vs. expected -$0.06) and achieved 100% launch success in 2025. Significant international expansion and validation include contracts with JAXA, ESA, the Canadian Space Agency, and a landmark $816M U.S. military deal.
Rocket Lab stock (RKLB) has experienced significant growth recently—up 67% in just a month. Should you invest now, or is this trend becoming too costly?
Rocket Lab surges 66.9% in a month, driven by launches and major contracts. However, premium valuation and high costs raise questions about buying the stock now.